학술논문
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
Document Type
Article
Author
Source
In Annals of Oncology June 2016 27(6):1013-1019
Subject
Language
ISSN
0923-7534